Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease
- PMID: 22257841
- DOI: 10.1016/j.jclinepi.2011.09.011
Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease
Abstract
Objective: In clinical trials, agreement on outcomes is of utmost importance for valid estimation of intervention effects. As there is limited knowledge about adjudicator agreement in cardiology, we examined the level of agreement among three cardiology specialists adjudicating all possible events in a randomized controlled clinical trial of patients with stable coronary heart disease.
Study design and setting: All information (hospital records, death certificates, etc.) was forwarded to two randomly selected blinded adjudicators. If they disagreed, the third arbiter had to choose the more likely of the two alternatives. Files of 5,475 nonfatal and 362 fatal events were evaluated.
Results: For nonfatal outcomes, pairwise kappa values ranged from 0.75 to 0.80. The three adjudicators had 4.3%, 9.5%, and 6.1% of their nonfatal outcome classifications overruled by their arbiter. If stable angina pectoris, unstable angina pectoris, and acute myocardial infarction were treated as one, agreement increased minimally. For fatal outcomes, the pairwise kappa values ranged from 0.65 to 0.90. The three adjudicators had 12%, 9%, and 10% of their death classifications overruled.
Conclusion: Specialists in cardiology can attain a reasonably high agreement on outcomes in patients with stable coronary heart disease.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Description and status of the azithromycin and coronary events study (ACES).J Infect Dis. 2000 Jun;181 Suppl 3:S579-81. doi: 10.1086/315628. J Infect Dis. 2000. PMID: 10839763 Clinical Trial.
-
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.BMJ. 2006 Jan 7;332(7532):22-7. doi: 10.1136/bmj.38666.653600.55. Epub 2005 Dec 8. BMJ. 2006. PMID: 16339220 Free PMC article. Clinical Trial.
-
Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.J Infect Dis. 2000 Jun;181 Suppl 3:S572-8. doi: 10.1086/315634. J Infect Dis. 2000. PMID: 10839762 Clinical Trial.
-
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.Circulation. 2007 May 15;115(19):2549-69. doi: 10.1161/CIRCULATIONAHA.107.182615. Circulation. 2007. PMID: 17502590 Review.
-
[Anti-angina therapy of coronary heart disease. Mono- or combination treatment].Z Kardiol. 1991 May;80(5):305-16. Z Kardiol. 1991. PMID: 1678565 Review. German.
Cited by
-
10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.J Am Heart Assoc. 2018 Apr 23;7(9):e008299. doi: 10.1161/JAHA.117.008299. J Am Heart Assoc. 2018. PMID: 29686027 Free PMC article. Clinical Trial.
-
Rivaroxaban Once-Daily vs. Dose-Adjusted Vitamin K Antagonist on Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF): Rationale and Design of an Investigator-Initiated Multicenter Randomized Prospective Open-Labeled Pilot Clinical Study.Front Cardiovasc Med. 2022 Jan 12;8:765081. doi: 10.3389/fcvm.2021.765081. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35096995 Free PMC article.
-
Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial.BMJ Open. 2020 Aug 20;10(8):e033720. doi: 10.1136/bmjopen-2019-033720. BMJ Open. 2020. PMID: 32819979 Free PMC article. Clinical Trial.
-
Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course.Open Heart. 2018 Sep 5;5(2):e000808. doi: 10.1136/openhrt-2018-000808. eCollection 2018. Open Heart. 2018. PMID: 30228904 Free PMC article.
-
Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial.Diagn Progn Res. 2017 Mar 29;1:10. doi: 10.1186/s41512-017-0009-y. eCollection 2017. Diagn Progn Res. 2017. PMID: 31093541 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials